{"id":"https://openalex.org/W7220358554","doi":"https://doi.org/10.3390/psychoactives5040027","title":"Private-Sector Sales Trends of Antidepressants and Antipsychotics in Costa Rica, 2022\u20132026: An Aggregate Analysis by Active Ingredient","display_name":"Private-Sector Sales Trends of Antidepressants and Antipsychotics in Costa Rica, 2022\u20132026: An Aggregate Analysis by Active Ingredient","publication_year":2026,"publication_date":"2026-10-03","ids":{"openalex":"https://openalex.org/W7220358554","doi":"https://doi.org/10.3390/psychoactives5040027"},"language":"en","primary_location":{"id":"doi:10.3390/psychoactives5040027","doi":"https://doi.org/10.3390/psychoactives5040027","is_oa":true,"landing_page_url":"https://doi.org/10.3390/psychoactives5040027","pdf_url":null,"source":{"id":"https://openalex.org/S4387280156","display_name":"Psychoactives","issn_l":"2813-1851","issn":["2813-1851"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychoactives","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3390/psychoactives5040027","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037139141","display_name":"Esteban Zavaleta\u2010Monestel","orcid":"https://orcid.org/0000-0003-3726-0079","observed_orcids":["https://orcid.org/0000-0003-3726-0079"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Esteban Zavaleta-Monestel","raw_affiliation_strings":["Health Research Department, Cl\u00ednica B\u00edblica, San Jos\u00e9 1307-1000, Costa Rica"],"raw_orcid":"https://orcid.org/0000-0003-3726-0079","affiliations":[{"raw_affiliation_string":"Health Research Department, Cl\u00ednica B\u00edblica, San Jos\u00e9 1307-1000, Costa Rica","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5128987850","display_name":"Luis Guillermo Herrera-Jim\u00e9nez","orcid":"https://orcid.org/0009-0009-9839-7109","observed_orcids":["https://orcid.org/0009-0009-9839-7109"]},"institutions":[{"id":"https://openalex.org/I31944674","display_name":"Universidad de Costa Rica","ror":"https://ror.org/02yzgww51","country_code":"CR","type":"education","lineage":["https://openalex.org/I31944674"]}],"countries":["CR"],"is_corresponding":false,"raw_author_name":"Luis Herrera-Jim\u00e9nez","raw_affiliation_strings":["Department of Pharmacy, University of Costa Rica, San Jos\u00e9 11501-2060, Costa Rica"],"raw_orcid":"https://orcid.org/0009-0009-9839-7109","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, University of Costa Rica, San Jos\u00e9 11501-2060, Costa Rica","institution_ids":["https://openalex.org/I31944674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070446816","display_name":"Sebasti\u00e1n Arguedas\u2010Chac\u00f3n","orcid":"https://orcid.org/0000-0001-8547-7745","observed_orcids":["https://orcid.org/0000-0001-8547-7745"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sebastian Arguedas-Chac\u00f3n","raw_affiliation_strings":["Health Research Department, Cl\u00ednica B\u00edblica, San Jos\u00e9 1307-1000, Costa Rica"],"raw_orcid":"https://orcid.org/0000-0001-8547-7745","affiliations":[{"raw_affiliation_string":"Health Research Department, Cl\u00ednica B\u00edblica, San Jos\u00e9 1307-1000, Costa Rica","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5129029272","display_name":"Jos\u00e9 Andr\u00e9s Castro-Gamboa","orcid":"https://orcid.org/0009-0009-0753-5124","observed_orcids":["https://orcid.org/0009-0009-0753-5124"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jose Castro-Gamboa","raw_affiliation_strings":["Pharmacy Department, Cl\u00ednica B\u00edblica, San Jos\u00e9 1307-1000, Costa Rica"],"raw_orcid":"https://orcid.org/0009-0009-0753-5124","affiliations":[{"raw_affiliation_string":"Pharmacy Department, Cl\u00ednica B\u00edblica, San Jos\u00e9 1307-1000, Costa Rica","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5118883017","display_name":"Kevin Cruz-Mora","orcid":"https://orcid.org/0009-0006-7272-1642","observed_orcids":["https://orcid.org/0009-0006-7272-1642"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin Cruz-Mora","raw_affiliation_strings":["Pharmacy Department, Cl\u00ednica B\u00edblica, San Jos\u00e9 1307-1000, Costa Rica"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Department, Cl\u00ednica B\u00edblica, San Jos\u00e9 1307-1000, Costa Rica","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117230174","display_name":"Jeaustin Mora-Jim\u00e9nez","orcid":"https://orcid.org/0009-0001-0543-2262","observed_orcids":["https://orcid.org/0009-0001-0543-2262"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeaustin Mora-Jim\u00e9nez","raw_affiliation_strings":["Health Research Department, Cl\u00ednica B\u00edblica, San Jos\u00e9 1307-1000, Costa Rica"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Research Department, Cl\u00ednica B\u00edblica, San Jos\u00e9 1307-1000, Costa Rica","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086256755","display_name":"Ricardo Mill\u00e1n-Gonz\u00e1lez","orcid":"https://orcid.org/0009-0002-5446-9368","observed_orcids":["https://orcid.org/0009-0002-5446-9368"]},"institutions":[{"id":"https://openalex.org/I31944674","display_name":"Universidad de Costa Rica","ror":"https://ror.org/02yzgww51","country_code":"CR","type":"education","lineage":["https://openalex.org/I31944674"]}],"countries":["CR"],"is_corresponding":false,"raw_author_name":"Ricardo Mill\u00e1n-Gonz\u00e1lez","raw_affiliation_strings":["School of Medicine, University of Costa Rica, San Jos\u00e9 11501-2060, Costa Rica"],"raw_orcid":"https://orcid.org/0009-0002-5446-9368","affiliations":[{"raw_affiliation_string":"School of Medicine, University of Costa Rica, San Jos\u00e9 11501-2060, Costa Rica","institution_ids":["https://openalex.org/I31944674"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5037139141"],"corresponding_institution_ids":[],"apc_list":{"value":1000,"currency":"CHF","value_usd":1207},"apc_paid":{"value":1000,"currency":"CHF","value_usd":1207},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":"4","first_page":"27","last_page":"27"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.7196999788284302,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.7196999788284302,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":0.12049999833106995,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.05169999971985817,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.9679999947547913},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":1.0},{"id":"https://openalex.org/keywords/defined-daily-doses","display_name":"defined daily doses","score":0.8880000114440918},{"id":"https://openalex.org/keywords/escitalopram","display_name":"escitalopram","score":0.9750000238418579},{"id":"https://openalex.org/keywords/sertraline","display_name":"sertraline","score":1.0},{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":0.9710000157356262},{"id":"https://openalex.org/keywords/desvenlafaxine","display_name":"desvenlafaxine","score":0.9900000095367432},{"id":"https://openalex.org/keywords/aripiprazole","display_name":"aripiprazole","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lurasidone","display_name":"lurasidone","score":1.0},{"id":"https://openalex.org/keywords/costa-rica","display_name":"Costa Rica","score":0.8080000281333923}],"concepts":[{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.6338000297546387},{"id":"https://openalex.org/C2776865356","wikidata":"https://www.wikidata.org/wiki/Q1182681","display_name":"Defined daily dose","level":3,"score":0.5230000019073486},{"id":"https://openalex.org/C2779583969","wikidata":"https://www.wikidata.org/wiki/Q423757","display_name":"Escitalopram","level":4,"score":0.5175999999046326},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.5126000046730042},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42100000381469727},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.37950000166893005},{"id":"https://openalex.org/C30772137","wikidata":"https://www.wikidata.org/wiki/Q5164762","display_name":"Consumption (sociology)","level":2,"score":0.37709999084472656},{"id":"https://openalex.org/C2776701107","wikidata":"https://www.wikidata.org/wiki/Q416992","display_name":"Lurasidone","level":4,"score":0.36899998784065247},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.36469998955726624},{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.3564999997615814},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.34689998626708984},{"id":"https://openalex.org/C12725497","wikidata":"https://www.wikidata.org/wiki/Q810247","display_name":"Baseline (sea)","level":2,"score":0.3467000126838684},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3465000092983246},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.30570000410079956},{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.27559998631477356},{"id":"https://openalex.org/C45904493","wikidata":"https://www.wikidata.org/wiki/Q912807","display_name":"Active ingredient","level":2,"score":0.27390000224113464},{"id":"https://openalex.org/C2778058735","wikidata":"https://www.wikidata.org/wiki/Q4692253","display_name":"Aggregate data","level":2,"score":0.2653999924659729}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3390/psychoactives5040027","doi":"https://doi.org/10.3390/psychoactives5040027","is_oa":true,"landing_page_url":"https://doi.org/10.3390/psychoactives5040027","pdf_url":null,"source":{"id":"https://openalex.org/S4387280156","display_name":"Psychoactives","issn_l":"2813-1851","issn":["2813-1851"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychoactives","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3390/psychoactives5040027","doi":"https://doi.org/10.3390/psychoactives5040027","is_oa":true,"landing_page_url":"https://doi.org/10.3390/psychoactives5040027","pdf_url":null,"source":{"id":"https://openalex.org/S4387280156","display_name":"Psychoactives","issn_l":"2813-1851","issn":["2813-1851"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychoactives","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1971924839","https://openalex.org/W2072303299","https://openalex.org/W2101582587","https://openalex.org/W2140107414","https://openalex.org/W2148429037","https://openalex.org/W2578164715","https://openalex.org/W2788337440","https://openalex.org/W2789087194","https://openalex.org/W2792027821","https://openalex.org/W2957311488","https://openalex.org/W2982167270","https://openalex.org/W3138882923","https://openalex.org/W3215716001","https://openalex.org/W4286500354","https://openalex.org/W4310702395","https://openalex.org/W4367046465","https://openalex.org/W4386437906","https://openalex.org/W4414171564","https://openalex.org/W7161954143"],"related_works":["https://openalex.org/W4301397043","https://openalex.org/W4309941908","https://openalex.org/W4323924816","https://openalex.org/W4409806529","https://openalex.org/W7000327906","https://openalex.org/W7113306713","https://openalex.org/W7131341097","https://openalex.org/W4413919559","https://openalex.org/W4327732795","https://openalex.org/W3194948537"],"abstract_inverted_index":{"Aggregated":[0],"pharmaceutical":[1,157],"sales":[2,28,58,139],"data":[3],"can":[4],"characterize":[5],"apparent":[6],"medication":[7],"consumption":[8],"and":[9,32,76,81,104,130],"changes":[10],"in":[11,34],"market":[12,158],"composition,":[13],"although":[14],"they":[15],"do":[16],"not":[17,162],"represent":[18],"individual":[19,173],"prescribing":[20],"or":[21,177],"patient":[22,179],"exposure.":[23,180],"This":[24],"study":[25,52],"described":[26],"private-sector":[27,138],"trends":[29],"of":[30,140,167],"antidepressants":[31],"antipsychotics":[33],"Costa":[35],"Rica":[36],"from":[37,87,96],"moving":[38],"annual":[39],"total":[40,168],"(MAT)":[41],"February":[42,46],"2022":[43],"to":[44,89,98,124,134],"MAT":[45],"2026.":[47],"An":[48],"observational,":[49],"descriptive,":[50],"longitudinal":[51],"was":[53,115,120],"conducted":[54],"using":[55],"aggregated":[56],"IQVIA":[57],"data.":[59],"Total":[60],"defined":[61],"daily":[62],"doses":[63],"(DDDs)":[64],"sold":[65,75],"were":[66],"analyzed":[67],"as":[68,165],"the":[69,107,116,121],"primary":[70],"indicator,":[71],"complemented":[72],"by":[73,78],"units":[74],"analyses":[77],"therapeutic":[79,142],"group":[80],"active":[82,149],"ingredient.":[83],"Antidepressant":[84],"DDDs":[85,94],"increased":[86,95],"15,299,281":[88],"17,976,312":[90],"(+17.5%),":[91],"whereas":[92,128],"antipsychotic":[93,135],"1,078,635":[97],"1,476,810":[99],"(+36.9%).":[100],"In":[101],"2026,":[102],"escitalopram":[103],"sertraline":[105],"had":[106],"highest":[108],"DDD":[109],"volumes":[110],"among":[111],"antidepressants,":[112],"while":[113],"quetiapine":[114],"leading":[117],"antipsychotic.":[118],"Desvenlafaxine":[119],"largest":[122],"contributor":[123],"net":[125],"antidepressant":[126],"growth,":[127],"aripiprazole":[129],"lurasidone":[131],"contributed":[132],"substantially":[133],"growth.":[136],"Overall,":[137],"both":[141],"groups":[143],"increased,":[144],"with":[145],"distinct":[146],"patterns":[147],"across":[148],"ingredients.":[150],"These":[151],"findings":[152],"provide":[153],"a":[154],"baseline":[155],"for":[156],"surveillance":[159],"but":[160],"should":[161],"be":[163],"interpreted":[164],"estimates":[166],"national":[169],"consumption,":[170],"public-sector":[171],"utilization,":[172],"prescribing,":[174],"clinical":[175],"indications,":[176],"actual":[178]},"counts_by_year":[],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2026-10-06T00:00:00"}